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Abstract: l o  assess maturation of central serotonin and 
catecholamine pathways at birth. we measured lumbar 
CSF homovanillic acid (HVA) and 5-hydroxyindoleacetic 
acid (5-HIAA). stable acid metabolites of dopamine and 
serotonin, using HPLC with electrochemical detection. 
CSFs from 57 neonates (38 premature and 19 at term) and 
13 infants 1-6 months old were studied. HVA levels in- 
creased with maturity (p < 0.05; ANOVA), whereas$5- 
HIAA levels were similar in all these subjects. HVA/5- 
HIAA ratios increased markedly from I + 0.12  in the 
most premature neonates to 1.98 + 0.17 in the older in- 
fants (p < 0.01: t test). There were no sex differences for 
these values. Key Words: Neonatal-Development- 
Serotonin-Dopamine-CCSF. Silverstein F. S. et al. 
Concentrations of homovanillic acid and 5-hydroxyin- 
doleacetic acid in cerebrospinal fluid from human infants 
in the perinatal period. J .  Neriloc.het?r. 43, 1769- 1772 
( 1984). 
Central catecholamine and serotonin neuronal path- 
ways originating in the brain stem participate in regula- 
tion of vital physiological functions of human infants, in- 
cluding respiration, sleep, feeding, temperature, and neu- 
roendocrine control (Gluckman et al., 1981; Yogman and 
Zeisel, 1983). Disruptions in these activities are common 
symptoms of central nervous system pathology in the 
neonatal period. The developmental state of neuronal me- 
tabolism in these pathways determines when they begin 
to have an impact on behavior (Coyle. 1977). Measure- 
ment of CSF concentrations of the stable acid metabolites 
of serotonin and dopamine is presently one of the few 
practical ways to study these pathways in humans. 
Levels of monoamine metabolites in cerebrospinal fluid 
and brain reflect biogenic amine neurotransmitter turn- 
over rates in the central nervous system of animals and 
humans (Papeshi et al., 1971; Garelis and Sourkes. 1973). 
Age-related changes in dopamine and serotonin metabo- 
lite levels have been reported in older children (Shaywitz 
et al., 1980; Seifert et al., 1980), but there are few reports 
of early developmental patterns in humans (Anderson 
and Roos, 1969; Bhat et al., 1983). To assess maturation 
and functional activity of catecholamine and serotonin 
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pathways at birth, we measured levels of homovanillic 
acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA). 
stable acid metabolites of dopamine and serotonin, in 
lumbar CSF from 57 neonates in the first 5 days of life. 
We assessed the influence of gestational age and gender 
on these values. and compared the levels with those in 
infants 1-6 months old. We also studied sequential 
lumbar CSFs and ventricular CSF in an infant who de- 
veloped obstruction of cerebrospinal fluid flow (hydro- 
cephalus) to learn more about bulk flow of the metabo- 
lites within the spinal fluid. 
SUBJECTS AND METHODS 
We assayed lumbar CSF specimens from two groups 
of patients, 57 neonates and 13 infants, and cerebroven- 
tricular CSF specimens from two premature infants. The 
neonates, 35 boys and 22 girls. were patients in  the 
Holden Perinatal Unit of the University of Michigan Med- 
ical Center. Their gestational ages. as determined by clin- 
ical assessment, ranged from 28 to 42 weeks: there were 
38 premature infants (36 weeks or less) and 19 term in- 
fants. Common medical problems in these patients in- 
Ahhreviations rrsed: ANOVA, Analysis of variance: 5-HIAA. 
5-Hydroxyindoleacetic acid; HVA, Homovanillic acid. 
I769 
1770 F .  S .  SILVERSTEIN ET AL.  
cluded prematurity, asphyxia, respiratory distress, and 
infection. However, examination of the data did not re- 
veal any relationship of these conditions to the mono- 
amine concentrations and they were analyzed together. 
All subjects had a lumbar puncture in the first 5 days of 
life; the most common medical reason for the procedure 
was suspicion of infection. Typically, the total volume of 
CSF removed from an infant was 3-4 cc. The last aliquot 
(‘h-1 cc) was used for monoamine metabolite determi- 
nations. Fluid was also available from 13 older infants. 
seven boys and six girls, who received lumbar puncture 
for similar indications. Cerebrospinal fluids were ana- 
lyzed in routine fashion and an aliquot was frozen at 
- 20°C for neurotransmitter metabolite assay. 
Cerebroventricular fluid was also obtained from two 
infants. In the infant who developed hydrocephalus, sev- 
eral lumbar spinal fluid samples were available for com- 
parison. 
HVA and 5-HIAA levels were measured using HPLC 
with electrochemical detection (Nielson and Johnston, 
1982). To prepare samples for analysis, they were thawed, 
an aliquot was added to an equal amount of 0.4 M per- 
chloric acid, and the sample was spun in a microfuge 
(Beckman) for 1 min. Twenty microliters of the super- 
natant was injected directly into the system, which in- 
cluded a pre-column (Brownlee), a C-18, 5-pm, reverse- 
phase column (Altex), and an electrochemical detector 
with glassy carbon electrode set at 0.8 V versus an Ag/ 
AgCl electrode (Bioanalytical System). The mobile phase 
was 0.1 M phosphate-citrate buffer. pH 3, with 0.0001 M 
EDTA and 0.012% sodium octyl sulfonate. Sodium octyl 
sulfonate was used because we also measured CSF do- 
pamine levels (results not reported). HVA and 5-HIAA 
peaks were identified by calculation of retention times 
and the peaks of CSF metabolites coeluted with those of 
added standards. Concentrations were calculated by 
comparison with peak heights of external standards 
(Sigma). Variation in measurement of the same sample 
over a 6-month period was about 10%. 
The effects of gestational age and sex on HVA and 5- 
HIAA levels were tested by two-way analysis of variance 
(ANOVA). To assess the interrelationship of HVA and 5 -  
HIAA levels, HVAiHIAA ratios for each subject and 
mean values for four age groups were calculated, and 
groups were compared by Student’s t test. 
RESULTS 
The infants were grouped into four age groups for anal- 
ysis: young prematures less than 32 weeks, prematures 
33-36 weeks, 37-42 weeks (full term), and older infants 
up to 6 months. HVA and 5-HIAA levels in the subjects 
are tabulated in Table 1 ; values from all premature infants 
are combined. HVA levels increased progressively with 
increasing maturity (p < 0.05; ANOVA). Although mean 
HVA values of girls are slightly higher than those of boys 
in each age group, these differences are not statistically 
significant. In contrast to HVA, 5-HIAA levels are similar 
in the three age groups (p > 0.5; ANOVA), and there are 
no significant sex differences. Mean 5-HIAA values in all 
three groups of infants are considerably higher than 
values in older children (Seifert et al., 1980). 
We also studied ventricular fluid from two subjects. 
HVA concentrations were 487 ngiml in the first and 712 
ngiml in the second, both more than three times as high 
TABLE 1. Homovanillic acid and 5- 
hydroxyindoleacetic acid levels it? cerebrospinal fluid 
Compares premature and term neonates and older infants 
5-HIAA HVA 
n (ngirnl) (ngiml) 
Group I .  Premature neonates 38 96 2 10 106 i- 10 
Group 2. Term neonates 19 104 i. 7 129 2 11 
Group 3. Infants 13 85 2 7 159 i- 9* 
Premature neonates range in gestational age from 28 to 36 
weeks, term neonates from 37 to 42 weeks. Infants were 1-6 
months of age. Values are means 2 SEM. 
* p < 0.05 using analysis of variance to compare all HVA 
values in the three groups. 
as lumbar CSF values in infants. HIAA concentrations 
were 181 ng/ml and 284 ng/ml, both about twice as high 
as in lumbar CSF. The second patient’s ventricular tap 
was performed because obstruction of CSF flow out of 
the ventricular system (hydrocephalus) developed on day 
49 of life. A lumbar CSF obtained the next day contained 
markedly reduced metabolite levels: HVA, 18 ng/ml, and 
5-HIAA, 40 ng/ml. The HVA concentration was 9% of 
that obtained in the infant two weeks before CSF obstruc- 
tion (202 ngiml) and the 5-HIAA concentration was 32% 
of the previous value (124 ngiml). 
In Fig. 1 ,  mean HVA/HIAA ratios are plotted for three 
groups of neonates and the older infants. The mean HVA/ 
HIAA ratio in the most immature infants (28-32 weeks 
gestation) is 1 .0 ? 0.12 (mean * SEM), whereas in the 
most mature group (1 week-6 months old) it is 1.98 * 
0.17 (p < 0.01, comparing these two groups by Student’s 
t test). 
DISCUSSION 
Measurement of CSF monoamine metabolite concen- 
trations currently provides the most accessible measure 
of functional activity of central dopaminergic and sero- 
<32 weeks 33-6 weeks 37-42 wmks Infants 
FIG. 1. The ratio of HVA to 5-HIAA values for each subject 
was calculated. Comparison of the HVAI5-HIAA ratios (mean 
2 SEM) in neonates, grouped according to gestational age 
[32 weeks or less (n = 12), 33-36 weeks (n = 26), 37 weeks 
or more (n = 19)], and infants 1-6 months old (n = 13); t 
indicates p < 0.01, comparing the most immature neonates 
with the infants using Student’s t test. 
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tonergic neurons. The brain is the major site of HVA 
synthesis (Papeshi et al., 1971; Garelis et al., 1973), and 
although up to 30% of 5-HIAA is produced in the spinal 
cord, the neurons of origin are in the brainstem (Loewy 
and McKellar, 1981). Our observations on an infant with 
obstruction of CSF flow out of the brain are consistent 
with these estimates. The hydrocephalus was associated 
with accumulation of metabolites in the lateral ventricle 
and reduced lumbar concentrations, HVA more than 5- 
HIAA. The results agree with reports on older human 
subjects (Post et al., 1973; Sjostrom et al., 1975) and ex- 
perimental animals (Gordon et al., 1975). 
Concentrations of monoamine neurotransmitter metab- 
olites in CSF are determined by the rates of synthesis, 
release, and degradation of the parent compounds as well 
as the rate and efficiency of elimination of metabolites 
from the brain and spinal fluid. Therefore, interpretation 
of our data must consider possible developmental 
changes in each of these factors. As reported by others 
(Anderson and Roos, 1969; Seifert et al., 1980), values 
for infants 1-6 months of age are considerably higher 
than those of older children and adults. This may reflect 
a relatively high monoamine turnover at this age and/or 
changes in metabolite clearance from the brain. Com- 
paring premature and term neonates, Bhat et al. (1983) 
found no difference in CSF HVA levels, but mean values 
were lower in the prematures, the variation was large, 
and relatively few subjects were included. In immature 
rodents, the turnover of serotonin and dopamine, mea- 
sured in terms of brain or CSF HVA and 5-HIAA, is 
relatively high compared with adult levels (Keller et al., 
1973; Shaywitz et al., 1983). 
Experimental work in animals suggests that the mode 
of metabolite clearance from CSF may change consid- 
erably during early development. Atack et al. (1974) 
showed that the major route of 5-HIAA efflux from brain 
to blood in newborn rats is through CSF pathways to the 
choroid plexus. At 30 days, more than 75% exits directly 
from brain to blood, presumably across the blood-brain 
capillary endothelial barrier via a probenecid-blockable 
organic acid transport system (Kartzinel et al., 1976; El- 
ghozi et al., 1983). Therefore, one reason for high HVA 
and 5-HIAA in infants may be that the CSF pool repre- 
sents a larger share of the metabolites formed at this age. 
Another hypothesis suggested to explain the inverse re- 
lationship between HVA and 5-HIAA levels and age is 
that the surface area for reabsorption of CSF by bulk flow 
is reduced in young, smaller children so that higher con- 
centrations are present in lumbar CSF (Seifert et al., 
1980). Although a gradient of HVA levels has been de- 
scribed in the lumbar sac of adults (Jakupcevic et al., 
1977), this is unlikely to be a factor in explaining the 
differences in infants since such small volumes were re- 
moved. Further, since all infants who had lumbar punc- 
tures were recumbent and relatively inactive, differences 
in amount of mixing of CSF are unlikely to account for 
the age-related changes. 
Our data indicate that HVA concentrations increase 
over the period from the last trimester of pregnancy into 
early infancy, while 5-HIAA levels are relatively stable. 
Thus, the HVA/5-HIAA ratio changes markedly over this 
time period. Since both metabolites are synthesized and 
cleared by very similar mechanisms, it is unlikely that 
either changes in transmitter degradative enzymes (Baker 
et al., 1974) or transport out of brain explains this differ- 
entiai effect. The data suggest that the maturation of 
human dopaminergic neuronal activity lags behind that 
of serotonin neurons in the perinatal period. This could 
be related to differences in neuronal development, to reg- 
ulatory alterations in other contiguous neuronal circuits, 
or to  changes in transmitter substrate availability 
(Yogman and Zeisel, 1983). Differences in the develop- 
mental patterns for individual neuronal groups have been 
described in experimental animals (Johnston and Coyle, 
1981), and it is likely that rates of biochemical differen- 
tiation also vary according to neuronal type in man. Do- 
pamine and serotonin are present in human fetal brain as 
early as 3 to 4 months gestation (Nobin et al., 1973). but 
regional brain levels of serotonin and dopamine have not 
been measured in infant human brain. 
There is considerable variation in metabolite levels 
among infants of the same gestational age. Factors such 
as intrauterine or perinatal stress, nutritional status, and 
genetic makeup may contribute to the regulation of rates 
of neuronal maturation. Thus, although developmental 
trends are clear, identification of pathological alterations 
in individual patients will require study of a larger number 
of patients or marked deviations from normal. 
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